ifoxetine has been researched along with piperidines in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, PA; Bischoff, S; Bittiger, H; Hauser, K; Maître, L; Paioni, R; Waldmeier, PC | 1 |
| Delini-Stula, A; Fischbach, R; Gauthier, JM; Richou, H; Rothweiler, G; Wendt, G; Wolfersdorf, M | 1 |
| Aichele, G; Antonin, KH; Bieck, PR; Gleiter, CH; Hengen, N; Nilsson, E | 1 |
| Fujimoto, K; Hirao, Y; Matsushita, C; Miyake, M; Tanaka, M; Tanaka, N | 1 |
| Adachi, S; Fujino, H; Heike, T; Hiramatsu, H; Hori, T; Kato, I; Saida, S; Umeda, K; Watanabe, K; Yamada, T | 1 |
1 trial(s) available for ifoxetine and piperidines
| Article | Year |
|---|---|
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugs.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperidines; Serotonin Antagonists | 1987 |
4 other study(ies) available for ifoxetine and piperidines
| Article | Year |
|---|---|
Ifoxetine, a compound with atypical effects on serotonin uptake.
Topics: Animals; Blood Platelets; Brain Chemistry; Corpus Striatum; Haloperidol; In Vitro Techniques; Myocardium; Nalidixic Acid; Naphthyridines; Neurotransmitter Agents; Norepinephrine; Piperidines; Rats; Serotonin; Synaptosomes; Tryptophan; Tyramine; Tyrosine | 1986 |
Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development.
Topics: Adult; Debrisoquin; Drug Evaluation; Female; Humans; Hydroxylation; Isoquinolines; Kinetics; Male; Phenotype; Piperidines; Polymorphism, Genetic; Serotonin | 1985 |
A case of small cell carcinoma of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Irinotecan; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Piperidines | 2007 |
Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Piperidines; Remission Induction; Rituximab | 2015 |